Edap TMS SA
FOCLNasdaqCIK 1041934HealthcareFiscal year ends Dec 31
Latest reported revenue, Q2 FY2026$13.2mRevenue, Q2 FY2026, three months to 2026-06-30$13.2m. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 14, 2026.Latest quarter: Q2 FY2026
Three months to Jun 30, 2026, against the same quarter a year earlier.
- Revenue$13.2mRevenue, Q2 FY2026, three months to 2026-06-30$13.2m. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure+38.8% on a year earlier - Gross margin55.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $7.3m. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure+4.4 pts on a year earlier - Operating margin−60.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$8.0m. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure+8.8 pts on a year earlier - Net margin−109.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$14.5m. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure−42.4 pts on a year earlier - Diluted EPS−$0.39Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure−129.4% on a year earlier - Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Shape over the periods |
|---|---|---|---|---|---|---|
| Revenue | $m | 14.3Revenue, period not labelled, three months to 2025-03-31$14.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | 9.5Revenue, period not labelled, three months to 2025-06-30$9.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | 17.8Revenue, Q1 FY2026, three months to 2026-03-31$17.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | 13.2Revenue, Q2 FY2026, three months to 2026-06-30$13.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | |
| Gross margin | % | 42.0%Gross margin, period not labelled, three months to 2025-03-31. gross profit / revenueGross profit: $6.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $14.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | 51.1%Gross margin, period not labelled, three months to 2025-06-30. gross profit / revenueGross profit: $4.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $9.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | 45.7%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $8.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $17.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | 55.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $7.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | |
| Operating margin | % | (44.2%)Operating margin, period not labelled, three months to 2025-03-31. operating income / revenueOperating income: −$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $14.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (69.6%)Operating margin, period not labelled, three months to 2025-06-30. operating income / revenueOperating income: −$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $9.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | (41.4%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $17.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (60.8%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | |
| Net margin | % | (52.2%)Net margin, period not labelled, three months to 2025-03-31. net income / revenueNet income: −$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $14.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (67.4%)Net margin, period not labelled, three months to 2025-06-30. net income / revenueNet income: −$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $9.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | (51.0%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Revenue: $17.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (109.7%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | |
| Diluted EPS | $ per share | (0.20)Diluted EPS, period not labelled, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (0.17)Diluted EPS, period not labelled, three months to 2025-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | (0.24)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057094.Report this figure | (0.39)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097063.Report this figure | |
| Free cash flow | $m | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20202020-12-31 | FY20212021-12-31 | FY20222022-12-31 | FY20242024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $m | 41.6Revenue, FY2020, twelve months to 2020-12-31EUR 41.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 20-F filed 2023-04-07, accession 0001558370-23-005629.Report this figure | 44.1Revenue, FY2021, twelve months to 2021-12-31EUR 44.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 20-F filed 2023-04-07, accession 0001558370-23-005629.Report this figure | 55.1Revenue, FY2022, twelve months to 2022-12-31EUR 55.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 20-F filed 2023-04-07, accession 0001558370-23-005629.Report this figure | 69.4Revenue, FY2024, twelve months to 2024-12-31$69.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | 70.5Revenue, FY2025, twelve months to 2025-12-31$70.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | 41.4%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $28.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $69.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | 42.5%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $30.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $70.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | (32.0%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $69.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | (35.0%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $70.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | |
| Net margin | % | not reported (Net income not reported) | not reported (Net income not reported) | not reported (Net income not reported) | (29.7%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $69.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | (41.5%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034528.Revenue: $70.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | (0.55)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | (0.78)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001104659-26-034528.Report this figure | |
| Free cash flow | $m | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 2026-06-30 | $37.9m | 7,309,254 | Unchanged | |
| MORGAN STANLEY | 2026-06-30 | $17.3m | 3,336,872 | Reduced−8,408 | |
| Rock Springs Capital Management LP | 2026-06-30 | $7.2m | 1,386,000 | Added+8,000 | |
| FLAX POND CAPITAL, LLC | 2026-06-30 | $3.8m | 736,230 | Reduced−47,216 | |
| FLAX POND CAPITAL, LLC | 2026-06-30 | $2.9m | 789,446 | Added+6,000 | |
| Bruce & Co., Inc. | 2026-06-30 | $2.3m | 438,652 | Unchanged | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-06-30 | $2.0m | 392,200 | Call | Added+311,400 |
| JANE STREET GROUP, LLC | 2026-06-30 | $1.4m | 271,500 | Call | Added+221,600 |
| CITADEL ADVISORS LLC | 2026-06-30 | $876.5k | 169,200 | Call | Added+96,600 |
| Parkman Healthcare Partners LLC | 2026-06-30 | $802.0k | 154,832 | Unchanged |
Recent filings
All 367 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1910:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-098487 |
| 2026-08-1420:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097063 |
| 2026-08-1410:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-096209 |
| 2026-08-1320:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005498 |
| 2026-08-1121:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094134 |
| 2026-06-2620:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-004324 |
| 2026-06-0120:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003840 |
| 2026-05-2911:30 ET | 8-K | 8.01 Other events | 0001171843-26-003773 |
| 2026-05-1411:30 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001104659-26-060700 |
| 2026-05-0720:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057094 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 1041934
- Tickers
- FOCL
- Exchange
- Nasdaq
- SIC code
- 3845 Electromedical & Electrotherapeutic Apparatus
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- not reported
- Filer category
- Non-accelerated filer<br>Smaller reporting company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.